As a service to our authors and readers, this journal provides supporting information supplied by the authors.

Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset.

Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.


Table S1. Transfer of CD8+ T cells primed in vitro with gCO-treated DCs does not induce diabetes

Figure S1. gCO treatment does not modify mature DC phenotype.

Figure S2. gCO-treated DCs induce normal in vitro CD8+ T-cell priming and function.

Figure S3. Screening of homing and chemokine receptors following DC-CD8 co-culture.

Figure S4. Autoreactive CD8+ T cells show normal in vitro lytic activity when stimulated with CO-treated DCs.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.